BOSTON SCIENTIFIC CORP Quarterly Nonoperating Income (Expense) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Boston Scientific Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2010 to Q3 2024.
  • Boston Scientific Corp Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$65M, a 21.7% increase year-over-year.
  • Boston Scientific Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$311M, a 9.12% decline year-over-year.
  • Boston Scientific Corp annual Nonoperating Income (Expense) for 2023 was -$358M, a 29.5% increase from 2022.
  • Boston Scientific Corp annual Nonoperating Income (Expense) for 2022 was -$508M, a 313% decline from 2021.
  • Boston Scientific Corp annual Nonoperating Income (Expense) for 2021 was -$123M, a 12400% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$311M -$65M +$18M +21.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-01
Q2 2024 -$329M -$100M -$12M -13.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$317M -$67M +$41M +38% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 -$358M -$79M -$73M -1217% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 -$285M -$83M +$31M +27.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-01
Q2 2023 -$316M -$88M -$10M -12.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$306M -$108M +$202M +65.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 -$508M -$6M +$54M +90% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$562M -$114M -$209M -220% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$353M -$78M +$35M +31% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$388M -$310M -$265M -589% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$123M -$60M -$317M -123% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $194M $95M +$117M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $77M -$113M -$3M -2.73% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $80M -$45M +$79M +63.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1M $257M +$473M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 -$472M -$22M +$270M +92.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$742M -$110M +$129M +54% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$871M -$124M -$40M -47.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$831M -$216M -$192M -800% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 -$639M -$292M -$360M -529% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$279M -$239M -$194M -431% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$85M -$84M $0 0% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$85M -$24M +$68M +73.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 -$153M $68M +$136M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$289M -$45M +$89M +66.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 -$378M -$84M -$25M -42.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 -$353M -$92M -$41M -80.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 -$312M -$68M +$23M +25.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-29
Q2 2017 -$335M -$134M -$71M -113% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 -$264M -$59M +$6M +9.23% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 -$270M -$51M +$59M +53.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-19
Q3 2016 -$329M -$91M -$23M -33.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$306M -$63M +$51M +44.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$357M -$65M +$10M +13.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$367M -$110M -$49M -80.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-20
Q3 2015 -$318M -$68M -$7M -11.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$311M -$114M -$79M -226% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 -$232M -$75M -$24M -47.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 -$208M -$61M +$7M +10.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 -$215M -$61M +$82M +57.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$297M -$35M +$33M +48.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$330M -$51M +$13M +20.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 -$343M -$68M -$2M -3.03% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-24
Q3 2013 -$341M -$143M -$74M -107% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 -$267M -$68M -$37M -119% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 -$230M -$64M +$9M +12.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$239M -$66M +$5M +7.04% Oct 1, 2012 Dec 31, 2012 10-K 2013-02-22
Q3 2012 -$244M -$69M -$6M -9.52% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 -$238M -$31M +$48M +60.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 -$286M -$73M -$24M -49% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-05-07
Q4 2011 -$262M -$71M +$47M +39.8% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-22
Q3 2011 -$309M -$63M +$25M +28.4% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 -$334M -$79M +$33M +29.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 -$367M -$49M +$40M +44.9% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
Q4 2010 -$407M -$118M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-22
Q3 2010 -$88M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$112M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
Q1 2010 -$89M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.